Markus Luster

Albert Einstein Allee 23
Ulm, BW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 167 publications

Optimal timing of post-therapeutic [131I]NaI whole-body scintigraphy in predominantly low- and intermediate-risk differentiated thyroid cancer: a secondary analysis of prospectively acquired data and a structured literature review.

Optimal timing of post-therapeutic [131I]NaI whole-body scintigraphy in predominantly low- and intermediate-risk differentiated thyroid cancer: a secondary analysis of prospectively acquired data and a structured literature review.

Journal: BMC medical imaging

Published: June 16, 2026

Thyroid Cancer: Epidemiology, Diagnosis, and Treatment.

Thyroid Cancer: Epidemiology, Diagnosis, and Treatment.

Journal: Deutsches Arzteblatt international

Published: April 22, 2026

Anaplastic thyroid cancer: Cases, incidence, prevalence and survival in Germany.

Anaplastic thyroid cancer: Cases, incidence, prevalence and survival in Germany.

Journal: Endocrine

Published: December 19, 2025

Novel imaging techniques for the differential diagnosis of adrenal tumors, pheochromocytomas and paragangliomas

Novel imaging techniques for the differential diagnosis of adrenal tumors, pheochromocytomas and paragangliomas

Journal: Chirurgie (Heidelberg, Germany)

Published: December 02, 2025

Functional PET for mapping metabolic dynamics in Parkinson's disease.

Functional PET for mapping metabolic dynamics in Parkinson's disease.

Journal: Scientific reports

Published: July 18, 2025

Theranostic Radiopharmaceuticals of Somatostatin Receptors for Patients with Neuroendocrine Tumors: Agonists Versus Antagonists-A Systematic Review and Meta-Analysis.

Theranostic Radiopharmaceuticals of Somatostatin Receptors for Patients with Neuroendocrine Tumors: Agonists Versus Antagonists-A Systematic Review and Meta-Analysis.

Journal: International journal of molecular sciences

Published: June 25, 2025

Response to letter: 'why so many doses, and why now?'

Response to letter: 'why so many doses, and why now?'

Journal: European thyroid journal

Published: May 21, 2025

Therapeutic Consequences of 68Ga-PSMA-11-PET/CT in Prostate Cancer in Correlation to the Gleason Score, PSA Value, and D'Amico-Defined Risk Groups.

Therapeutic Consequences of 68Ga-PSMA-11-PET/CT in Prostate Cancer in Correlation to the Gleason Score, PSA Value, and D'Amico-Defined Risk Groups.

Journal: Cancers

Published: May 07, 2025

Mutation-based, neoadjuvant treatment for advanced anaplastic thyroid carcinoma.

Mutation-based, neoadjuvant treatment for advanced anaplastic thyroid carcinoma.

Journal: Frontiers in endocrinology

Published: April 28, 2025

Predictive factors of radioiodine ablation success: results from a MEDIRAD prospective clinical study for thyroid cancer.

Predictive factors of radioiodine ablation success: results from a MEDIRAD prospective clinical study for thyroid cancer.

Journal: European thyroid journal

Published: March 25, 2025

Autoimmune thyroiditis in paediatric thyroid cancer: clinical features and outcomes.

Autoimmune thyroiditis in paediatric thyroid cancer: clinical features and outcomes.

Journal: European journal of endocrinology

Published: March 17, 2025

PET imaging utilization and trends in Germany: a comprehensive survey.

PET imaging utilization and trends in Germany: a comprehensive survey.

Journal: European journal of nuclear medicine and molecular imaging

Published: February 04, 2025

Showing 1-12 of 167

Last Updated: 09/26/2026